Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-To-Severe Atopic Dermatitis
AuthID
P-010-BF2
P-010-BF2
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service